FAKTOR OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000UL50MX2

Market Closed - Deutsche Boerse AG 13:32:59 2024-06-27 EDT
0.49 EUR -10.91% Intraday chart for FAKTOR OPTIONSSCHEIN - MEDTRONIC
Current month-17.91%
1 month-26.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-27 0.49 -10.91%
24-06-26 0.55 -1.79%
24-06-25 0.56 -11.11%
24-06-24 0.63 0.00%
24-06-21 0.63 +10.53%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 01:32 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer UBS
WKN UL50MX
ISINDE000UL50MX2
Date issued 2023-07-14
Strike 70.04 $
Maturity Unlimited
Parity 16.4 : 1
Emission price 5.09
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 6.22
Lowest since issue 0.47
Spread 0.03
Spread %5.56%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
80.05 USD
Average target price
94.02 USD
Spread / Average Target
+17.46%
Consensus